• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价可改变的肾癌风险因素。

Systematic review of modifiable risk factors for kidney cancer.

机构信息

Department of Urology, University of Texas Health Science Center San Antonio, San Antonio, TX.

Department of Internal Medicine, Columbia University, New York, NY.

出版信息

Urol Oncol. 2019 Jun;37(6):359-371. doi: 10.1016/j.urolonc.2018.12.008. Epub 2019 Jan 24.

DOI:10.1016/j.urolonc.2018.12.008
PMID:30685335
Abstract

To perform a systematic review of modifiable risk factors associated with the incidence of renal cell cancer (RCC). A systematic search of the literature was conducted using PubMed, Cochrane, and Web of Science databases from January 1996 until August 2017. We also extracted articles from the reference lists of identified studies and reviews. We targeted modifiable risk factors for RCC to include exercise, smoking, alcohol, diet, obesity, hypertension, and diabetes. We utilized predefined inclusion criteria and the Preferred Reporting Items for Systematic Reviews and Meta-analysis statement. We identified a total of 464 relevant articles and excluded 209 via title and 130 after abstract review. We thoroughly reviewed a total of 125 manuscripts. Seven supplementary tables describe (a) case controls and (b) prospective cohort studies. We summarize the tables in figures to visualize the overall impact of these studies association (beneficial, harmful, or null) with RCC. Total physical activity if beneficial (10/12 studies), smoking is harmful (13/14 studies), alcohol was protective (i.e., beneficial, 13/16 studies), diet was indeterminate (13 beneficial, 13 harmful, and 9 nulls), obesity and hypertension were overwhelmingly harmful (36/36 studies and 17/18, respectively), and diabetes was detrimental (23/27 studies). Modifiable risk factors play an essential role in the development of RCC, and we should develop targeted RCC prevention strategies in at-risk individuals.

摘要

目的

系统评价与肾细胞癌(RCC)发病相关的可改变风险因素。系统检索了 1996 年 1 月至 2017 年 8 月期间PubMed、Cochrane 和 Web of Science 数据库中的文献。我们还从确定的研究和综述的参考文献中提取了文章。我们将 RCC 的可改变风险因素确定为运动、吸烟、饮酒、饮食、肥胖、高血压和糖尿病。我们采用了预先确定的纳入标准和系统评价和荟萃分析报告的首选条目。我们共确定了 464 篇相关文章,通过标题排除了 209 篇,通过摘要排除了 130 篇。我们详细审查了总共 125 篇论文。7 个补充表格描述了(a)病例对照和(b)前瞻性队列研究。我们将表格汇总为图,以直观地展示这些研究与 RCC 的总体关联(有益、有害或无效)的影响。总体力活动有益(12 项研究中有 10 项),吸烟有害(14 项研究中有 13 项),饮酒有保护作用(即有益,16 项研究中有 13 项),饮食不确定(13 项有益,13 项有害,9 项无效),肥胖和高血压的危害极大(36 项研究和 17 项研究分别有 36 项和 18 项),糖尿病有害(27 项研究中有 23 项)。可改变的风险因素在 RCC 的发展中起着重要作用,我们应该在高危人群中制定有针对性的 RCC 预防策略。

相似文献

1
Systematic review of modifiable risk factors for kidney cancer.系统评价可改变的肾癌风险因素。
Urol Oncol. 2019 Jun;37(6):359-371. doi: 10.1016/j.urolonc.2018.12.008. Epub 2019 Jan 24.
2
Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial.降低肾细胞癌发病率的可改变风险因素:来自前列腺、肺癌、结直肠癌和卵巢癌(PLCO)试验的见解。
Urol Oncol. 2018 Jul;36(7):340.e1-340.e6. doi: 10.1016/j.urolonc.2018.04.011. Epub 2018 May 17.
3
Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition.预防肾癌的发生和复发:生活方式、药物和营养。
Curr Opin Urol. 2018 Jan;28(1):62-79. doi: 10.1097/MOU.0000000000000454.
4
Racial Disparities and Preventive Measures to Renal Cell Carcinoma.种族差异与肾细胞癌的预防措施。
Int J Environ Res Public Health. 2018 May 28;15(6):1089. doi: 10.3390/ijerph15061089.
5
Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention.当代肾细胞癌的流行病学:初级预防的视角。
World J Urol. 2010 Jun;28(3):247-52. doi: 10.1007/s00345-010-0555-1.
6
7
The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.包含饮食成分的体重管理干预措施对孕妇和产后女性体重相关结局的影响:一项系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):88-98. doi: 10.11124/jbisrir-2015-1812.
8
Consumption of fruits and vegetables and risk of renal cell carcinoma: a meta-analysis of observational studies.水果和蔬菜的摄入量与肾细胞癌风险:观察性研究的荟萃分析
Oncotarget. 2017 Apr 25;8(17):27892-27903. doi: 10.18632/oncotarget.15841.
9
Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention.成人肾细胞癌的危险因素:一项系统综述及预防意义
BJU Int. 2000 Jul;86(1):20-7. doi: 10.1046/j.1464-410x.2000.00708.x.
10
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.欧洲泌尿外科学会肾癌指南:2019 年更新版。
Eur Urol. 2019 May;75(5):799-810. doi: 10.1016/j.eururo.2019.02.011. Epub 2019 Feb 23.

引用本文的文献

1
Increasing incidence of early-onset kidney cancer in young adults aged <50 years in England: an analysis of the national cancer registration data by age and gender, 1985-2020.英格兰50岁以下年轻人早发性肾癌发病率上升:1985 - 2020年按年龄和性别的国家癌症登记数据分析
BJC Rep. 2025 May 14;3(1):32. doi: 10.1038/s44276-025-00149-y.
2
Efficacy of First-Line Treatments for Advanced Renal Cell Carcinoma: A Bayesian Network Meta-analysis of Objective Response, Progression-Free Survival, and Overall Survival.晚期肾细胞癌一线治疗的疗效:客观缓解、无进展生存期和总生存期的贝叶斯网络荟萃分析
Target Oncol. 2025 May;20(3):375-387. doi: 10.1007/s11523-025-01147-3. Epub 2025 May 6.
3
Long-term outcomes and survival rates of renal cell carcinoma patients in Erbil, Iraq: a follow-up study.
伊拉克埃尔比勒肾细胞癌患者的长期结局和生存率:一项随访研究
BMC Cancer. 2025 Mar 3;25(1):384. doi: 10.1186/s12885-024-13040-9.
4
Correlation Between BMI and Kidney Tumor Lateralization: Insights into Survival and Risk Factors.体重指数与肾肿瘤侧别之间的相关性:对生存及危险因素的见解
Cancers (Basel). 2024 Dec 12;16(24):4139. doi: 10.3390/cancers16244139.
5
Research progress on the correlation between obesity and the occurrence and development of kidney cancer: a narrative review.肥胖与肾癌发生发展的相关性研究进展:一项叙述性综述
Transl Cancer Res. 2024 Oct 31;13(10):5678-5690. doi: 10.21037/tcr-24-744. Epub 2024 Oct 29.
6
Prognosis impact and clinical findings in renal cancer patients: comparative analysis between public and private health coverage in a cross-sectional and multicenter context.肾癌患者的预后影响及临床发现:横断面多中心背景下公共与私人医疗保险的比较分析
Cancer Causes Control. 2025 Mar;36(3):265-273. doi: 10.1007/s10552-024-01891-3. Epub 2024 Nov 8.
7
Ultra-processed food consumption and renal cell carcinoma incidence and mortality: results from a large prospective cohort.超加工食品的消费与肾细胞癌的发病率和死亡率:一项大型前瞻性队列研究的结果。
BMC Med. 2024 Oct 14;22(1):459. doi: 10.1186/s12916-024-03677-5.
8
Exploring the gut microbiome and immunological landscape in kidney cancer: a Mendelian randomization analysis.探讨肾癌中的肠道微生物组和免疫景观:一项孟德尔随机化分析。
Front Immunol. 2024 Aug 29;15:1459967. doi: 10.3389/fimmu.2024.1459967. eCollection 2024.
9
The risk of solid organ tumors in patients with chronic kidney disease: A narrative review of literature.慢性肾脏病患者实体器官肿瘤的风险:文献综述
Heliyon. 2024 Jun 24;10(13):e32822. doi: 10.1016/j.heliyon.2024.e32822. eCollection 2024 Jul 15.
10
Subsequent Renal Cancer Among Childhood Cancer Survivors: Analysis of Surveillance, Epidemiology, and End Results.儿童癌症幸存者的后续肾癌:监测、流行病学和最终结果分析。
J Pediatr Hematol Oncol. 2024 Aug 1;46(6):e387-e392. doi: 10.1097/MPH.0000000000002910. Epub 2024 Jun 24.